510(k) Report

510(k) · Cleared

Cleared

Collawound Art

K093351510(k) AbbreviatedCleared Jun 16, 2010232-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Collamatrix, Inc. · FRO Dressing, Wound, Drug

Cleared on Jun 16, 2010 as substantially equivalent to K051647 (Organogenesis, Inc., 2005) and 1 other predicate after a 232-day review. Its family tree reaches back 4 generations to 1997.

Decided
Jun 16, 2010
Review
232 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K970566 (1997). 10 ancestors in all, the oldest K895993 (1990). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2002: 1 other ancestor2001: 1 other ancestor2000: 1 other ancestor1998: 1 other ancestor1997: 1 other ancestor1990: 1 other ancestorK970566 · Arglaes Film Dressing · Maersk Medical, Ltd. · 1997K990810 · Arglaes-AB Antimicrobial Barrier Film Dressing & Island Dressing · Maersk Medical, Ltd. · 1999K024054 · Xylos Xcell Antimicrobial Dressing · Xylos Corporation · 2003K051647 · Fortaderm Antimicrobial Wound Dressing · Organogenesis, Inc. · 200519901995200020052010
  1. Root · 4 generations backK970566 Arglaes Film DressingMaersk Medical, Ltd. · 1997
  2. 3 generations backK990810 Arglaes-AB Antimicrobial Barrier Film Dressing & Island DressingMaersk Medical, Ltd. · 1999
  3. 2 generations backK024054 Xylos Xcell Antimicrobial DressingXylos Corporation · 2003
  4. 1 generation backK051647 Fortaderm Antimicrobial Wound DressingOrganogenesis, Inc. · 2005
  5. This deviceK093351 Collawound ArtCollamatrix, Inc. · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K970566Arglaes Film DressingMaersk Medical, Ltd.1997—
−3K990810Arglaes-AB Antimicrobial Barrier Film Dressing & Island DressingMaersk Medical, Ltd.1999—
−2K024054Xylos Xcell Antimicrobial DressingXylos Corporation2003—
−1K051647Fortaderm Antimicrobial Wound DressingOrganogenesis, Inc.2005—
0 (this device)K093351Collawound ArtCollamatrix, Inc.2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199710
199810
200010
200110
200210
FIG. 1 — Lineage of K093351, 1997–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051647Fortaderm Antimicrobial Wound DressingOrganogenesis, Inc.2005—
*K024054Xylos Xcell Antimicrobial Dressing
Summary page 2
…hexamethylene Biguanide Hydrochloride (PHMB) (KO5 1647) Comparn': Organogenesis Inc. Trade name: XCeII Antimicrobial Cellulose Wound Dressing (K024054) Company: XylosO Corporation The proposed device, CollaWound ART, is another PHMB-containing wound dressing…
Xylos Corporation2003—

Also cleared against K051647: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 4 companies; a new generation was cleared every 3.5 years on median.
  • 1 of the 10 ancestors has a recall of any class.
  • 1 other device also cites its predicate K051647.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

CollnWound ART is a wound dressing intended for use as a barrier to resist microbial colonization within the dressing and reduce microbial penetration through the dressing. CohnaWound ART is intended for the management of wounds including:

* partial and full thickness wounds

* pressure ulcers

* venous ulcers

* diabetic ulcers

* chronic vascular ulcers

* tunneled/undermined wounds

* surgical wounds (donor sites/grafts, post-Moli's surgery, post-laser surgery, wound dehiscence)

* trauma wounds (abrasions, lacerations, second-degree bumns, and skin tears)

* draining wounds

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093351: Collawound Art.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K093351

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026